← Eichor
Study identifier: NCT07032987 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Improving Sedation Practice in Critically Ill Adult Patients Using a Co-designed Sedation Protocol

Condition: Intensive Care Medicine · Respiratory Distress Syndrome (RDS) · Sedation and Analgesia  ·  Sponsor: Guy's and St Thomas' NHS Foundation Trust

PhaseN/A
Planned participants120
Who can joinAll sexes, 18 Years to 100 Years
Healthy volunteersNo

About this study

Sedation (painkillers and sedative drugs) treats pain, reduces suffering, and helps patients in the intensive care unit (ICU) receiving extracorporeal membrane oxygenation (ECMO) remain comfortable. ECMO is a life support machine that provides oxygen and removes waste gases (carbon dioxide) in very sick patients with severe heart or lung failure. About 300-400 patients per year receive ECMO in the UK. These patients are younger and generally more healthy compared to other critically ill patients. However patients that survive ECMO have long-term health problems. These include anxiety, memory problems, withdrawal from medicines, and mobility issues. These problems issues could all be related to the type and amount of sedation given. A sedation protocol is a way of guiding healthcare professionals how much sedation is given to patients in ICU. Too much sedation can cause confusion, hallucinations, excessive sleepiness, and longer time in hospital. Too little sedation can cause pain, distress, and also a longer time in hospital. Using a sedation protocol in non-ECMO patients has been shown to reduce these complications. However, there are no protocols for giving sedation to ECMO patients in research papers. The investigators know healthcare staff find it difficult to manage sedation, and higher amounts of sedation is given to ECMO patients. Aims: * To describe current sedation use in ECMO patients in the UK and compare to non-ECMO critically ill patients. * To develop a seda…

This description comes directly from the study's public registry record.

Talk to the study team

Christopher Remmington, MPharm  ·  +442078365454  ·  christopher.remmington@nhs.net

Louise Rose, PhD  ·  +4478365454  ·  louise.rose@kcl.ac.uk

Always discuss trial participation with your own doctor first.

Locations (1)

Guy's and St Thomas' NHS Foundation TrustLondon, London, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07032987